India Health Fund, along with the Wadhwani Research Center for Bioengineering, IIT Bombay, and GH Labs, co-hosted a consultation on “Diagnostics Market Drivers in India and the Potential for Global Impact” at IIT Bombay. The day-long session was attended by innovators, academicians, regulatory experts, government representatives, activists, disease survivors, clinicians, and funders, all with a common vision: the drive to apply key diagnostic innovations to tackle infectious diseases like TB in India and beyond. The discussion centered around the diagnostics landscape in India and the roadblocks to making technology accessible to people across the country.